The DOI matches its Crossref record; 59 of the 61 references it cites were found in a registry or an index.
Histone acetylation and transcriptional regulatory mechanisms
Open accessAbstract
More than 30 years ago, Vincent Allfrey proposed that histone acetylation was associated with transcriptional activity in eukaryotic cells (Allfrey et al. 1964; Pogo et al. 1966). Subsequently, acetylated core histones were shown to preferentially associate with transcriptionally active chromatin (Sealy and Chalkley 1978; Vidali et al. 1978; Hebbes et al. 1988). Acetylation occurs at lysine residues on the amino-terminal tails of the histones, thereby neutralizing the positive charge of the histone tails and decreasing their affinity for DNA (Hong et al. 1993). As a consequence, histone acetylation alters nucleosomal conformation (Norton et al. 1989), which can increase the accessibility of transcriptional regulatory proteins to chromatin templates (Lee et al. 1993; Vettese-Dadey et al. 1996). Taken together, these observations suggested how histone acetylation could result in increased transcriptional activity in vivo. However, there was essentially no information about the cause and effect relationship between histone acetylation and transcriptional activity or about the underlying molecular mechanisms. A mechanistic and physiologically relevant connection between histone acetylation and transcriptional regulation was initially provided by two independent lines of evidence. First, yeast cells unable to acetylate the histone H4 tail because of mutations of the target lysine residues show altered patterns of transcription (Durrin et al. 1991). However, these mutations broadly affect chromatin structure in vivo, and hence are likely to influence other molecular processes involving DNA (e.g., DNA replication and repair, recombination, chromosome segregation). Second, treatment of mammalian cells with potent inhibitors of histone deacetylase activity such as trapoxin or trichostatin A resulted in increased expression of a variety of genes (Yoshida et al. 1995). However, these drugs might inhibit other cellular targets, and they affect a variety of cellular processes, including cell proliferation, apoptosis, differentiation, and DNA synthesis. Although these observations were suggestive, understanding of the relationship between chromatin structure and transcription regulation was hampered significantly by a lack of knowledge about the enzymes that acetylate and deacetylate histones. In the past 2 years, our understanding of the causal relationship between histone acetylation and gene expression has been enhanced dramatically by the identification of proteins with intrinsic histone acetylase and deacetylase activity (Brownell et al. 1996; for recent reviews, see Grunstein 1997; Pazin and Kadonaga 1997; Wade et al. 1997). Of particular significance, some of these enzymes had been identified previously as components of the RNA polymerase II (Pol II) transcription machinery itself, proteins that associate with transcriptional regulatory factors, or proteins that positively or negatively affect transcription in vivo. These discoveries have led to a major paradigm shift. It is now clear that chromatin structure and modification can not be viewed as a process that is independent of transcriptional initiation, that is, chromatin is not simply a structure that serves to compact DNA in the nucleus and provide a relatively passive substrate for the action of transcription factors. Instead, histone acetylases and deacetylases provide a critical link between chromatin structure and transcriptional output, and this link is now accessible to experimental intervention. This review will focus on molecular mechanisms by which histone acetylation affects transcriptional activity in living cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Histone deacetylation promotes the condensation of chromatin which, in turn, promotes transcriptional repression (Struhl, 1998).”
From Structural Snapshots of Human HDAC8 Provide Insights into the Class I Histone Deacetylases (2004) · cites this paper as Struhl, 1998
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As for histone modification, it impacts chromatin structure and DNA packaging (37) [e.g., the acetylation of histones may render DNA more or less accessible to transcription factors, leading to enhanced or reduced transcriptional activity (53)].”
From Epigenetic Modifications in Stress Response Genes Associated With Childhood Trauma (2019) · cites this paper as [53]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Histone acetylation in chromatin structure and transcription
Grunstein, M. (1997) · Nature · doi:10.1038/38664 · Cited by 2,884
ACETYLATION AND METHYLATION OF HISTONES AND THEIR POSSIBLE ROLE IN THE REGULATION OF RNA SYNTHESIS
Allfrey, V. G., Faulkner, R. D., & Mirsky, A. E. (1964) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.51.5.786 · Cited by 2,788
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
A Mammalian Histone Deacetylase Related to the Yeast Transcriptional Regulator Rpd3p
Taunton, J., Hassig, C. A., & Schreiber, S. L. (1996) · Science · doi:10.1126/science.272.5260.408 · Cited by 1,829
The CBP co-activator is a histone acetyltransferase
Bannister, A. J., & Kouzarides, T. (1996) · Nature · doi:10.1038/384641a0 · Cited by 1,828
Brownell, J. E., Zhou, J., Ranalli, T. A., Kobayashi, R., Edmondson, D. G., Dent, S., & Allis, C. D. (1996) · Cell · doi:10.1016/s0092-8674(00)81063-6 · Cited by 1,636
A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
Yang, X., Ogryzko, V. V., Nishikawa, J., Howard, B. H., & Nakatani, Y. (1996) · Nature · doi:10.1038/382319a0 · Cited by 1,497
Chen, H., Lin, R. J., Schiltz, R. L., Chakravarti, D., Nash, A., Nagy, L., Privalsky, M. L., Nakatani, Y., & Evans, R. M. (1997) · Cell · doi:10.1016/s0092-8674(00)80516-4 · Cited by 1,480
Steroid receptor coactivator-1 is a histone acetyltransferase
Spencer, T. E., Jenster, G. W., Burcin, M. M., Allis, C. D., Zhou, J., Mizzen, C. A., McKenna, N. J., Oñate, S. A., Tsai, S. Y., Tsai, M., et al. (1997) · Nature · doi:10.1038/38304 · Cited by 1,242
Flagged first, then by citations
2 of the 61 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Rundlett, S.E., A.A. Carmen, R. Kobayashi, S. Bavykin, B.M. Turner, and M. Grunstein. 1996. HDA1 and RPD3 are mem- bers of distinct yeast histone deacetylase complexes. Proc. Natl. Acad. Sci. 93: 14503-14508.
Cited by
Sorted by citations
Items 501–600 of 1,002
Li, T., Liu, T., Zhu, W., Xie, S., Zhao, Z., Feng, B., Guo, H., & Yang, R. (2021) · Clinical Medicine Insights Oncology · doi:10.1177/11795549211035540 · Cited by 98
Effects of histone acetylation and DNA methylation on p21WAF1regulation
Fang, J. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i3.400 · Cited by 102
YARNELL, A., Oh, S., Reinberg, D., & Lippard, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101208200 · Cited by 96
Zeng, X., Li, X., Miller, A., Yuan, Z.-M., Yuan, W., Kwok, R. P. S., Goodman, R. H., & Lu, H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.4.1299-1310.2000 · Cited by 97
Qiao, Y., Wang, R., Yang, X., Tang, K., & Jing, N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.603761 · Cited by 111
Epigenetics in multiple myeloma: From mechanisms to therapy
Alzrigat, M., Párraga, A. A., & Jernberg‐Wiklund, H. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.09.007 · Cited by 95
Glucocorticoid receptor-mediated chromatin remodeling in vivo
Deroo, B. J., & Archer, T. (2001) · Oncogene · doi:10.1038/sj.onc.1204328 · Cited by 95
Epstein–Barr virus EBNA2 blocks Nur77- mediated apoptosis
Lee, J. M., Lee, K.-H., Weidner-Glunde, M., Osborne, B. A., & Hayward, S. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182552499 · Cited by 95
Steady-state Levels of Histone Acetylation in Saccharomyces cerevisiae
Waterborg, J. H. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.17.13007 · Cited by 95
Boutillier, A., Trinh, E., & Loeffler, J. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01581.x · Cited by 94
Epigenetic regulation and gene markers as signals of early somatic embryogenesis
Mahdavi-Darvari, F., Noor, N. M., & Ismanizan, I. (2014) · Plant Cell Tissue and Organ Culture (PCTOC) · doi:10.1007/s11240-014-0615-0 · Cited by 94
Wang, H., Yu, N., Chen, D., Lee, K. C. L., Lye, P. L., Chang, J. W. W., Deng, W., Ng, M., Lu, T., Khoo, M. L., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm2003552 · Cited by 93
Sharma, V. M., Tomar, R. S., Dempsey, A., & Reese, J. C. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02311-06 · Cited by 96
Cell totipotency: molecular features, induction, and maintenance
Lu, F., & Zhang, Y. (2015) · National Science Review · doi:10.1093/nsr/nwv009 · Cited by 96
Galdieri, L. C., Gatla, H. R., Vancurova, I., & Vančura, A. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.742247 · Cited by 96
hADA3 is required for p53 activity
Wang, T., Kobayashi, T., Takimoto, R., Denes, A. E., Snyder, E. L., El‐Deiry, W. S., & Brachmann, R. K. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6404 · Cited by 93
Zarnegar, R., Brunaud, L., Kanauchi, H., Wong, M. G., Fung, M., Ginzinger, D. G., Duh, Q., & Clark, O. H. (2002) · Surgery · doi:10.1067/msy.2002.128690 · Cited by 93
Epigenetic changes in tumor Fas levels determine immune escape and response to therapy
Maecker, H. L., Yun, Z., Maecker, H. T., & Giaccia, A. J. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00095-8 · Cited by 93
Histone hyperacetylated domains across the Ifng gene region in natural killer cells and T cells
Chang, S., & Aune, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502129102 · Cited by 94
Activation of the BRLF1 promoter and lytic cycle of Epstein-Barr virus by histone acetylation
Chang, L.-K. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.20.3918 · Cited by 93
Attenuated DNA Damage Repair by Trichostatin A through BRCA1 Suppression
Zhang, Y., Carr, T., Dimtchev, A., Zaer, N., Dritschilo, A., & Jung, M. (2007) · Radiation Research · doi:10.1667/rr0811.1 · Cited by 93
Follicle-Stimulating Hormone Promotes Histone H3 Phosphorylation on Serine-10
DeManno, D. A., Cottom, J. E., Kline, M. P., Peters, C. A., Maizels, E. T., & Hunzicker-Dunn, M. E. (1999) · Molecular Endocrinology · doi:10.1210/me.13.1.91 · Cited by 93
Richon, V. M., Zhou, X., Rifkind, R. A., & Marks, P. A. (2001) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2000.0376 · Cited by 93
Chromatin modification by DNA tracking
TRAVERS, A. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13634 · Cited by 93
Li, J., Fu, J., Toumazou, C., Yoon, H., & Wong, J. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0298 · Cited by 92
Cascade of Distinct Histone Modifications during Collagenase Gene Activation
Martens, J. H. A., Verlaan, M., Kalkhoven, E., & ZANTEMA, A. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.5.1808-1816.2003 · Cited by 91
Specific Acetylation of Chromosomal Protein HMG-17 by PCAF Alters Its Interaction with Nucleosomes
Herrera, J. E., Sakaguchi, K., Bergel, M., Trieschmann, L., Nakatani, Y., & Bustin, M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3466 · Cited by 91
Kontaraki, J. E., Chen, H.-H., Riggs, A. D., & Bonifer, C. (2000) · Genes & Development · doi:10.1101/gad.14.16.2106 · Cited by 90
Sanderson, L., Taylor, G. W., Aboagye, E. O., Alao, J. P., Latigo, J. R., Coombes, R. C., & Vigushin, D. M. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.000638 · Cited by 90
Epigenetic alterations underlying autoimmune diseases
Aslani, S., Mahmoudi, M., Karami, J., Jamshidi, A., Malekshahi, Z., & Nicknam, M. H. (2016) · Autoimmunity · doi:10.3109/08916934.2015.1134511 · Cited by 94
Aberrant lysine acetylation in tumorigenesis: Implications in the development of therapeutics
Kaypee, S., Sudarshan, D., Shanmugam, M. K., Mukherjee, D., Sethi, G., & Kundu, T. K. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.01.011 · Cited by 89
Kong, X., van Diepeningen, A. D., van der Lee, T., Waalwijk, C., Xu, J., Xu, J., Zhang, H., Chen, W., & Feng, J. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00654 · Cited by 93
Kim, Y., Park, S.-M., Ha, H. C., Lee, A. R., Won, H., Cha, H., Cho, S., & Cho, J. M. (2020) · Journal of Cancer · doi:10.7150/jca.44622 · Cited by 93
The PCAF acetylase complex as a potential tumor suppressor
Schiltz, R. L., & Nakatani, Y. (2000) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(99)00037-2 · Cited by 90
Trichostatin A Inhibits Corneal Haze In Vitro and In Vivo
Sharma, A., Mehan, M. M., Sinha, S., Cowden, J. W., & Mohan, R. R. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2919 · Cited by 90
Kinetic and Mass Spectrometric Analysis of p300 Histone Acetyltransferase Domain Autoacetylation
Balasubramanyam, K., Jiang, L., Wang, L., Kelleher, N. L., & Cole, P. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608813200 · Cited by 90
Hattori, T., Coustry, F., Stephens, S., Eberspaecher, H., Takigawa, M., Yasuda, H., & Crombrugghe, B. D. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn150 · Cited by 90
Therapeutic potential of selective modulators of nuclear receptor action
Resche-Rigon, M., & Gronemeyer, H. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80126-9 · Cited by 90
Direct Examination of Histone Acetylation on Myc Target Genes Using Chromatin Immunoprecipitation
Eberhardy, S. R., D'Cunha, C. A., & Farnham, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005154200 · Cited by 91
Hsieh, W., Sutter, B. M., Ruess, H., Barnes, S. D., Malladi, V. S., & Tu, B. P. (2022) · Molecular Cell · doi:10.1016/j.molcel.2021.12.015 · Cited by 94
Comparative analysis of HD2 type histone deacetylases in higher plants
Dangl, M., Brosch, G., Haas, H., Loidl, P., & Lusser, A. (2001) · Planta · doi:10.1007/s004250000506 · Cited by 88
Multiple, dispersed human U6 small nuclear RNA genes with varied transcriptional efficiencies
Domitrovich, A. M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg331 · Cited by 89
Modulation of cellular radiation responses by histone deacetylase inhibitors
Karagiannis, T. C., & El‐Osta, A. (2006) · Oncogene · doi:10.1038/sj.onc.1209417 · Cited by 89
Johnson, C. A., Padget, K., Austin, C. A., & Turner, B. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c000824200 · Cited by 87
Bianchi, M., Renzini, A., Adamo, S., & Moresi, V. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18040840 · Cited by 90
Epigenetic regulation in cancer therapy: From mechanisms to clinical advances
Tao, L., Zhou, Y., Luo, Y., Qiu, J., Xiao, Y., Zou, J., Zhang, Y., Liu, X., Yang, X., Gou, K., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.59 · Cited by 95
Huang, S., Qiu, Y., Shi, Y., Xu, Z., & Brandt, S. J. (2000) · The EMBO Journal · doi:10.1093/emboj/19.24.6792 · Cited by 91
Jiang, J. C., Wawryn, J., Kumara, H. M. C. S., & Jazwinski, S. M. (2002) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00064-5 · Cited by 88
Li, X., Song, S., Liu, Y., Ko, S.-H., & Kao, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405179200 · Cited by 88
Transcriptional regulatory mechanisms of the human apolipoprotein genes in vitro and in vivo
Zannis, V. I., Kan, H.-Y., Κritis, A., Zanni, E. E., & Kardassis, D. (2001) · Current Opinion in Lipidology · doi:10.1097/00041433-200104000-00012 · Cited by 86
Phosphorylation and an ATP-dependent process increase the dynamic exchange of H1 in chromatin
Dou, Y., Bowen, J. K., Liu, Y., & Gorovsky, M. A. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200202131 · Cited by 89
Love, I. M., Šekaric, P., Shi, D., Grossman, S. R., & Androphy, E. J. (2012) · Cell Cycle · doi:10.4161/cc.20864 · Cited by 89
Acetylation of histone H2B marks active enhancers and predicts CBP/p300 target genes
Narita, T., Higashijima, Y., Kilic, S., Liebner, T., Walter, J., & Choudhary, C. (2023) · Nature Genetics · doi:10.1038/s41588-023-01348-4 · Cited by 98
Signaling to the circadian clock: plasticity by chromatin remodeling
Nakahata, Y., Grimaldi, B., Sahar, S., Hirayama, J., & Sassone‐Corsi, P. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.016 · Cited by 89
AMF-1/Gps2 Binds p300 and Enhances Its Interaction with Papillomavirus E2 Proteins
Peng, Y.-C., Breiding, D. E., Sverdrup, F. M., Richard, J. G., & Androphy, E. J. (2000) · Journal of Virology · doi:10.1128/jvi.74.13.5872-5879.2000 · Cited by 86
The adenovirus protein Gam1 interferes with sumoylation of histone deacetylase 1
Colombo, R., Boggio, R., Seiser, C., Draetta, G. F., & Chiocca, S. (2002) · EMBO Reports · doi:10.1093/embo-reports/kvf213 · Cited by 87
Targeted Recruitment of Histone Acetyltransferase Activity to a Locus Control Region
Elefant, F., Cooke, N. E., & Liebhaber, S. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13827 · Cited by 87
Coactivators for the Orphan Nuclear Receptor RORα
Atkins, G. B., Hu, X., Guenther, M. G., Rachez, C., Freedman, L. P., & Lazar, M. A. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.9.0343 · Cited by 87
Lan, H., Sun, R., Fan, K., Yang, K., Zhang, F., Nie, X. Y., Wang, X., Zhuang, Z., & Wang, S. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01324 · Cited by 87
Histone deacetylase inhibitors activate p21(WAF1) expression via ATM.
Ju, R., & Muller, M. T. (2003) · PubMed · Cited by 86
Histone deacetylases in fungi: novel members, new facts
Trojer, P. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg473 · Cited by 86
Aliño, S. F., Crespo, A., & Dası́, F. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302065 · Cited by 85
Epigenetic regulation of established human type 1 versus type 2 cytokine responses
Su, R., Becker, A. B., Kozyrskyj, A. L., & HayGlass, K. T. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.004 · Cited by 85
Vries, R. G. J., Prudenziati, M., Zwartjes, C. G. M., Verlaan, M., Kalkhoven, E., & ZANTEMA, A. (2001) · The EMBO Journal · doi:10.1093/emboj/20.21.6095 · Cited by 86
Suppression of Adiponectin Gene Expression by Histone Deacetylase Inhibitor Valproic Acid
Qiao, L., Schaack, J. B., & Shao, J. (2005) · Endocrinology · doi:10.1210/en.2005-1030 · Cited by 87
Histone modification enzymes: novel targets for cancer drugs
Kristeleit, R. S., Stimson, L., Workman, P., & Aherne, W. (2004) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.9.1.135 · Cited by 86
CpG Islands in Chromatin Organization and Gene Expression
Kundu, T. K., & Rao, M. R. S. (1999) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a022276 · Cited by 86
Super-enhancers: a new frontier for epigenetic modifiers in cancer chemoresistance
Li, G., Qu, Q., Qi, T.-T., Teng, X.-Q., Zhu, H., Wang, J., Lu, Q., & Qu, J. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-01974-y · Cited by 89
Hipertrofia cardiaca: eventos moleculares y celulares
Carreño, J. E., Apablaza, F., Ocaranza, M. P., & Jalil, J. (2006) · Revista Española de Cardiología · doi:10.1157/13087900 · Cited by 84
Chang, T.-H., & Szabo, E. M. (2002) · PubMed · Cited by 83
Regulation of chromatin and chromosome morphology by histone H3 modifications in pig oocytes
Bui, H., Thuan, N. V., Kishigami, S., Wakayama, S., Hikichi, T., Ohta, H., Mizutani, E., Yamaoka, E., Wakayama, T., & Miyano, T. (2007) · Reproduction · doi:10.1530/rep-06-0099 · Cited by 84
Chen, C., Deng, Z., Kim, A. Y., Blobel, G. A., & Lieberman, P. M. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.2.476-487.2001 · Cited by 84
Tassara, M. G., Döhner, K., Brossart, P., Held, G., Götze, K. S. S., Horst, H.-A., Ringhoffer, M., Köhne, C., Kremers, S., Raghavachar, A., et al. (2014) · Blood · doi:10.1182/blood-2013-12-546283 · Cited by 83
Cryo-ET reveals the macromolecular reorganization of S. pombe mitotic chromosomes in vivo
Cai, S., Chen, C., Tan, Z. Y., Huang, Y., Shi, J. R., & Gan, L. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720476115 · Cited by 82
Broad domains of histone H3 lysine 4 trimethylation in transcriptional regulation and disease
Park, S., Kim, G. W., Kwon, S. H., & Lee, J. (2020) · FEBS Journal · doi:10.1111/febs.15219 · Cited by 88
Epigenetic modifications in prostate cancer
Sugiura, M., Sato, H., Kanesaka, M., Imamura, Y., Sakamoto, S., Ichikawa, T., & Kaneda, A. (2020) · International Journal of Urology · doi:10.1111/iju.14406 · Cited by 83
Posttranslational modifications of human histone H3: An update
Xu, Y., Du, J.-Y., & Lau, A. T. Y. (2014) · PROTEOMICS · doi:10.1002/pmic.201300435 · Cited by 89
Hyperinsulinemia and hypertriglyceridemia, a vicious cycle with atherogenic potential.
Steiner, G. A., & Vranić, M. (1982) · PubMed · Cited by 83
Genes on B chromosomes: Old questions revisited with new tools
Banaei‐Moghaddam, A. M., Martis, M. M., Macas, J., Gundlach, H., Himmelbach, A., Altschmied, L., Mayer, K., & Houben, A. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.11.007 · Cited by 82
Gonadotropin Signaling in the Ovary
Hunzicker-Dunn, M. E., & Mayo, K. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00020-x · Cited by 81
A brief history of circannual time
Lincoln, G. A. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12694 · Cited by 82
Shimono, Y., Murakami, H., Kawai, K., Wade, P. A., Shimokata, K., & Takahashi, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309198200 · Cited by 82
Schübeler, D., Groudine, M., & Bender, M. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201394698 · Cited by 87
Wulhfard, S., Baldi, L., Hacker, D. L., & Wurm, F. M. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.05.003 · Cited by 81
Histone Modifications and Chromatin Organization in Prostate Cancer
Chen, Z., Wang, L., Wang, Q., & Li, W. (2010) · Epigenomics · doi:10.2217/epi.10.31 · Cited by 82
A Novel Corepressor, BCoR-L1, Represses Transcription through an Interaction with CtBP
Pagan, J. K., Arnold, J. M., Hanchard, K. J., Kumar, R., Bruno, T., Jones, M. V., Richard, D. J., Forrest, A. R. R., Spurdle, A. B., Verdin, E. M., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700246200 · Cited by 81
Liu, Z., Wong, J., Tsai, S. Y., Tsai, M., & O’Malley, B. W. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9485 · Cited by 81
Metalloproteases as potential therapeutic targets in arthritis treatment
Rowan, A. D., Litherland, G. J., Hui, W., & Milner, J. M. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.1.1 · Cited by 80
Histone-Dependent Association of Tup1-Ssn6 with Repressed Genes In Vivo
Davie, J. K., Trumbly, R. J., & Dent, S. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.3.693-703.2002 · Cited by 80
Cyclin-dependent kinase inhibitors: novel anticancer agents
Mani, S., Wang, C., Wu, K., Francis, R., & Pestell, R. G. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.8.1849 · Cited by 80
Cook, T. A., & Urrutia, R. A. (2000) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2000.278.4.g513 · Cited by 81
Kabotyanski, E. B., Huetter, M., Xian, W., Rijnkels, M., & Rosen, J. M. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0160 · Cited by 79
Gillenwater, A. M., Zhong, M., & Lotan, R. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0344 · Cited by 79
Aiolos and Ikaros: Regulators of lymphocyte development, homeostasis and lymphoproliferation
Schmitt, C., Tonnelle, C., Dalloul, A. H., Chabannon, C., Debré, P., & Rebollo, A. (2002) · APOPTOSIS · doi:10.1023/a:1015372322419 · Cited by 80
Yi, M., Tong, G. X., Murry, B. A., & Mendelson, C. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109793200 · Cited by 79
Martínez‐Campa, C., Politis, P. K., Moreau, J.-L., Kent, N., GOODALL, J. C., Mellor, J., & Goding, C. R. (2004) · Molecular Cell · doi:10.1016/j.molcel.2004.05.022 · Cited by 77
de la Fuente, C., Santiago, F., Deng, L., Eadie, C., Zilberman, I., Kehn‐Hall, K., Maddukuri, A., Baylor, S., Wu, K., Lee, C. G., et al. (2002) · BMC Biochemistry · doi:10.1186/1471-2091-3-14 · Cited by 79
Chung, P. J., Kim, Y. S., Jeong, J. S., Park, S. H., Nahm, B. H., & Kim, J. (2009) · The Plant Journal · doi:10.1111/j.1365-313x.2009.03908.x · Cited by 78
Angus, W. G. R. (1999) · Carcinogenesis · doi:10.1093/carcin/20.6.947 · Cited by 78
Identification and Functional Characterization of the p66/p68 Components of the MeCP1 Complex
Feng, Q. F., Cao, R., Xia, L., Erdjument‐Bromage, H., Tempst, P., & Zhang, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.536-546.2002 · Cited by 78
Metadata
- Authors
- Struhl, K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Struhl, K.
- ORCID
- Struhl, K.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1998-03-01
- Volume
- 12
- Issue
- 5
- Pages
- 599-606
- ISSN
- 0890-9369 (ISSN-L)
- OpenAlex
- W2106900373
- Cited by
- 1,815
- References
- 61
- Citations by year
- 2026: 16 · 2025: 23 · 2024: 36 · 2023: 35 · 2022: 34 · 2021: 40 · 2020: 40 · 2019: 45 · 2018: 48 · 2017: 65 · 2016: 51 · 2015: 48 · 2014: 57 · 2013: 49 · 2012: 47
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Genes & Development (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (GM30186)
- National Institute of General Medical Sciences (GM30186, GM-53720, R01GM053720)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Keywords
- histone acetylation, histone deacetylase, transcriptional regulation, chromatin structure, histone acetyltransferase, nucleosome conformation, histone lysine acetylation, histone methylation, histone phosphorylation, histone H3, histone H2A
- MeSH terms
- Acetylation, Acetylesterase, Acetyltransferases, Animals, Gene Expression Regulation, Histone Deacetylases, Histones, Models, Biological, Proteins, Transcription Factors, Transcription, Genetic, Saccharomyces cerevisiae Proteins, Histone Acetyltransferases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review